Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy

Japanese Journal of Infectious Diseases

Volumn 64, Issue 2, 2011, Pages 133-138

  Takayanagi, Kiyoko ^a   Aoki, Misako ^a   Aman, Kumiko ^a   Mitarai, Satoshi ^b   Harada, Nobuyuki ^b   Higuchi, Kazue ^b   Okumura, Masao ^a   Yoshiyama, Takashi ^a   Ogata, Hideo ^a   Mori, Toru ^a  

^a Respiratory Medicine   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG MONITORING; DRUG RESPONSE; FEMALE; HUMAN; MALE; PROTEIN DETERMINATION; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CLINICAL LABORATORY TECHNIQUES; DRUG MONITORING; FEMALE; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RADIOGRAPHY, THORACIC; TUBERCULOSIS;

EID: 79955638039     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mori, T., Sakatani, M., Yamagishi, F., et al. (2004): Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am. J. Respir. Crit. Care Med., 170, 59-64.
2. Pai, M., Zwerling, A. and Menzies, D. (2008): T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med., 149, 177-184.
3. Mazurek, G.H., Jereb, J., Lobue. P., et al. (2005): Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. Morbid. Mortal. Wkly. Rep., 54 (RR-15), 49-55.
4. Lalvani, A. (2004): Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin. Infect. Dis., 38, 757-759.
5. Harada, N., Higuchi, K., Yoshiyama, T., et al. (2008): Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J. Infect., 56, 348-353.
6. Recommendation of Treatment Committee (2002): Japanese Society for Tuberculosis. Revision of standards for treatment of tuberculosis. Kekkaku, 77, 537-538 (in Japanese).
7. Committee for Prevention of Tuberculosis (2006): Japan Tuberculosis Society. Guidelines for the use of QuantiFERON TB-2G. Kekkaku, 81, 393-397 (in Japanese).
8. Snedecor, G.W. and Cochran, W.G. (1967): Statistical Methods. 6th ed. Iowa Univ. Press, p. 432.
9. Lalvani, A., Nagvenkar, P., Udwadia, Z., et al. (2001): Enumeration of T cells for RD1 encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis., 183, 469-477.
10. Pathan, A.A., Wilkinson, K.A., Kleneman, P., et al. (2001): Direct ex vivo analysis of antigen specific IFN-gamma secreting CD4 T cells in Mycobacterium tuberculosis infected individuals: associations with clinical disease state and effect of treatment. J. Immunol., 167, 5217-5225.
11. Carrrara, S., Vincenti, D., Petrosillo, N., et al. (2004): T cell-based assay for monitoring the course of antituberculosis therapy. Clin. Infect. Dis., 38, 754-756.
12. Dheda, K., Pooran, A., Pai, M., et al. (2007): Interpretation of Mycobacterium tuberculosis antigen-specific IFN-γ release assays (TSPOT. TB) and factors that may modulate test results. J. Infect., 55, 169-173.
13. Ewer, K., Millington, K.A., Deeks, J.J., et al. (2006): Dynamic antigenspecific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med., 174, 831-839.
14. Higuchi, K., Harada, N. and Mori, T. (2008): Interferon-γ responses after isoniazid chemotherapy for latent tuberculosis. Respirology, 13, 468-472.
15. Pai, M., Joshi, R., Bandyopadhyay, M., et al. (2007): Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection, 35, 98-103.
16. Pai, M., Joshi, R., Dogra, S., et al. (2006): Persistently elevated T cell interferon-γ responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J. Occup. Med. Toxicol., 1:7. doi:10.1186/1745-6673-1-7.
17. Ferrand, R.A., Bothamley, G.H., Whelan, A., et al. (2005): Interferongamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int. J. Tuberc. Lung Dis., 9, 1034-1039.
18. Ulrichs, T., Anding, P., Kaufmann, S.H.E., et al. (2000): Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int. J. Tuberc. Lung Dis., 4, 1181-1183.
19. Wilkinson, K.A., Kon, O.M. and Newton, S.M. (2006): Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J. Infect. Dis., 193, 354-359.
20. Nicol, M.P., Pienaar, D., Wood, K., et al. (2005): Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin. Infect. Dis., 40, 1301-1308.
21. Harada, N., Higuchi, K., Sekiya, Y., et al. (2004): Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10. Kekkaku, 79, 725-735 (article in Japanese with English summary).
22. Jensen, P.A., Lambert, L.A., Iademarco, M.F., et al. (2005): Centers for Disease, Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. Morbid. Mortal. Wkly. Rep., 54 (RR-17), 1-141.
23. Pai, M., Joshi, R., Dogra, S., et al. (2009): T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int. J. Tuberc. Lung Dis., 13, 84-92.
24. Menzies, D., Pai, M. and Comstock, G. (2007): Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med., 146, 340-354.
25. Lee, J.Y., Choi, H.J., Park, I.N., et al. (2006): Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur. Respir. J., 28, 24-30.
26. Hill, P.C., Brookes, R.H., Fox, A., et al. (2007): Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med., 4, e192.
27. Mori, T., Harada, N., Higuchi, K., et al. (2007): Waning of the specific interferon-gamma response after years of tuberculosis infection. Int. J. Tuberc. Lung Dis., 11, 1021-1025.